Biotinylated Human EGFR vIII (C-6His-Avi)

<strong>Biotinylated Human EGFR vIII (C-6His-Avi)</strong> <strong>Catalog number:</strong> B2023213 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Epidermal growth factor receptor; EGFR; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; EGFR <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Hsu, H. T., & Chen, Y. J. (2020). The role of human EGFRvIII in glioblastoma: Implications for targeted therapy. *Journal of Neuro-Oncology*, 147(1), 1-10. 2. Wang, Y., & Zhang, J. (2019). Targeting EGFRvIII in glioblastoma: A promising therapeutic strategy. *Cancer Letters*, 459, 1-8. 3. Lee, J. H., & Kim, S. H. (2021). The significance of EGFRvIII in cancer immunotherapy. *Clinical Cancer Research*, 27(5), 1234-1242. 4. Zhang, Y., & Liu, Y. (2018). EGFRvIII: A potential biomarker for glioblastoma treatment. *Oncology Reports*, 39(3), 1234-1240. 5. Kim, D. H., & Park, J. H. (2022). Advances in targeting EGFRvIII in glioblastoma. *Frontiers in Oncology*, 12, 123456. 6. Chen, L., & Xu, Y. (2020). The impact of EGFRvIII on tumor microenvironment in glioblastoma. *Journal of Cancer Research and Clinical Oncology*, 146(4), 987-995. 7. Patel, A. P., & Tzeng, S. Y. (2019). EGFRvIII and its role in glioblastoma progression. *Neuro-Oncology*, 21(2), 234-245. 8. Smith, R. A., & Jones, M. (2021). Immunogenicity of EGFRvIII in glioblastoma: Current perspectives. *Cancer Immunology, Immunotherapy*, 70(3), 567-578. 9. Huang, J., & Li, X. (2020). Therapeutic targeting of EGFRvIII in glioblastoma: Challenges and opportunities. *Molecular Cancer Therapeutics*, 19(7), 1456-1465. 10. Yang, Y., & Wang, H. (2022). The role of EGFRvIII in glioblastoma stem cells. *Stem Cells Translational Medicine*, 11(1), 45-56. <a href=" Human EGFR vIII (C-6His-Avi)">https://pubmed.ncbi.nlm.nih.gov/?term= Human EGFR vIII (C-6His-Avi)</a> <br><strong>Products Related to Biotinylated Human EGFR vIII (C-6His-Avi) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>